PwC's Next in Health

著者: PwC's Health Industries
  • サマリー

  • Co -hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.

    © 2025 PwC Next in Health
    続きを読む 一部表示

あらすじ・解説

Co -hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.

© 2025 PwC Next in Health
エピソード
  • Next in Pharma: The 2025 Outlook—The Future is Now
    2025/03/19

    Tune in as PwC's Pharmaceutical & Life Sciences Advisory Leader, Greg Rotz reflects on key market dynamics and explores how pharma leaders can tackle challenges including the $400 billion patent cliff, increasing competition, drug pricing pressures, and transformative disruptions shaping the industry. Discussion highlights:

    • Understanding the scale and implications of the upcoming patent cliff and economic pressures from regulatory changes like the Inflation Reduction Act
    • Examining heightened competition across therapeutic areas and the rapid emergence of rival treatments affecting market economics
    • Highlighting the necessity for bold strategic moves and critical capabilities, including AI innovation, portfolio optimization, strategic partnerships, and comprehensive risk management
    • Addressing disruptive forces such as geopolitical uncertainty, tariff impacts, and the rise of global innovation influencing pharmaceutical markets
    • Emphasizing the urgency for pharma leaders to embrace innovation and transformative strategies to improve healthcare affordability, accessibility, and quality

    Speakers:

    Greg Rotz, Pharmaceutical & Life Sciences Leader,PwC
    Glenn Hunzinger, Health Industries Leader, PwC
    Jenny Colapietro, Consulting Commercial Leader, PwC

    Linked materials:

    Next in pharma 2025: The future is now

    Pharmaceutical and life sciences: US Deals 2025 outlook

    President Donald J. Trump’s healthcare agenda


    For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

    続きを読む 一部表示
    22 分
  • Next in Health: The 2025 Outlook for Health Services
    2025/02/17

    Tune in as PwC specialists discuss the 2025 healthcare outlook, reflecting on 2024’s significant events and exploring how payers and providers can navigate rising costs, scrutiny, AI advances, and policy shifts with resilience and adaptability.

    Topics include:

    • Medicare and Medicaid drive industry growth amid rising competition, market exits, M&A, AI adoption, and policy challenges.
    • AI's potential to enhance healthcare delivery, improve workforce management, and optimize patient care.
    • The care-at-home market is growing rapidly, driven by demand and cost efficiency, but sustainability remains a challenge.
    • Encouragement for healthcare organizations to adapt and innovate in response to policy shifts and technological advancements.

    Speakers:
    Thom Bales, Health Services Leader, PwC
    Alena Taylor, Principal, PwC
    Ruchita Kewalramani, Principal, PwC
    Glenn Hunzinger, Health Industries Leader, PwC
    Jenny Colapietro, Consulting Commercial Leader, PwC

    Linked materials:

    • Next in Health: The 2025 Outlook for Health Services: https://www.pwc.com/us/en/industries/health-industries/library/healthcare-trends.html
    • Health Policy and Intelligence Institute: https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.html


    For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

    続きを読む 一部表示
    31 分
  • Health Industries: U.S. Deals Outlook for 2025 and Beyond
    2025/01/06

    Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:

    Key topics include:

    • A look back at M&A activity in health industries in 2024
    • The challenges and potential impediments that could affect deal volumes in the coming year
    • How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
    • Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors


    Speakers:
    Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
    Nick Donkar, Health Services Deals Leader, PwC
    Jenny Colapietro, Consulting Commercial Leader, PwC

    Linked materials:

    • https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
    • https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html


    For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

    続きを読む 一部表示
    25 分

PwC's Next in Healthに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。